{"id":"https://openalex.org/W2010671389","doi":"https://doi.org/10.1021/jm00021a009","title":"Piperazinylalkyl Heterocycles as Potential Antipsychotic Agents","display_name":"Piperazinylalkyl Heterocycles as Potential Antipsychotic Agents","publication_year":1995,"publication_date":"1995-10-01","ids":{"openalex":"https://openalex.org/W2010671389","doi":"https://doi.org/10.1021/jm00021a009","mag":"2010671389","pmid":"https://pubmed.ncbi.nlm.nih.gov/7473547"},"language":"en","primary_location":{"id":"doi:10.1021/jm00021a009","doi":"https://doi.org/10.1021/jm00021a009","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00021a009","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112269322","display_name":"Malcolm K. Scott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Malcolm K. Scott","raw_affiliation_strings":["R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania 19477, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania 19477, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002993261","display_name":"Ellen W. Baxter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ellen W. Baxter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023476078","display_name":"Debra J. Bennett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debra J. Bennett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113752947","display_name":"Robert E. Boyd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert E. Boyd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020308542","display_name":"Paul S. Blum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul S. Blum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111902792","display_name":"Ellen E. Codd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ellen E. Codd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026862766","display_name":"Michael J. Kukla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J. Kukla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001940670","display_name":"Elizabeth A. Malloy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Malloy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5070787633","display_name":"Bruce E. Maryanoff","orcid":"https://orcid.org/0000-0003-3590-2357","observed_orcids":["https://orcid.org/0000-0003-3590-2357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce E. Maryanoff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.853,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.71712463,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"38","issue":"21","first_page":"4198","last_page":"4210"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.42289999127388,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.42289999127388,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.23229999840259552,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13876","display_name":"Chemical synthesis and pharmacological studies","score":0.08259999752044678,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9139999747276306},{"id":"https://openalex.org/keywords/conditioned-avoidance-response","display_name":"conditioned avoidance response","score":0.9039999842643738},{"id":"https://openalex.org/keywords/d2-receptor-binding","display_name":"D2 receptor binding","score":0.8029999732971191},{"id":"https://openalex.org/keywords/5-ht1a-receptor-binding","display_name":"5-HT1A receptor binding","score":0.9919999837875366},{"id":"https://openalex.org/keywords/acid-stability","display_name":"acid stability","score":0.765999972820282},{"id":"https://openalex.org/keywords/thiophene","display_name":"thiophene","score":0.6679999828338623},{"id":"https://openalex.org/keywords/furan","display_name":"furan","score":0.9810000061988831},{"id":"https://openalex.org/keywords/isoxazolines","display_name":"isoxazolines","score":0.9340000152587891},{"id":"https://openalex.org/keywords/pyridine","display_name":"pyridine","score":0.984000027179718},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9513317346572876},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6374053359031677},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4302715063095093},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.34217581152915955},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.32154279947280884},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.17295825481414795},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.09016680717468262},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.06015273928642273},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001362","descriptor_name":"Avoidance Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001392","descriptor_name":"Azocines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001392","descriptor_name":"Azocines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001392","descriptor_name":"Azocines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002462","descriptor_name":"Cell Membrane","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003213","descriptor_name":"Conditioning, Psychological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005663","descriptor_name":"Furans","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005663","descriptor_name":"Furans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005663","descriptor_name":"Furans","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D010881","descriptor_name":"Piperidones","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010881","descriptor_name":"Piperidones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010881","descriptor_name":"Piperidones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011916","descriptor_name":"Rats, Inbred F344","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm00021a009","doi":"https://doi.org/10.1021/jm00021a009","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00021a009","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:7473547","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7473547","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2953285221","https://openalex.org/W4244258795","https://openalex.org/W2023567327","https://openalex.org/W1993273313","https://openalex.org/W2056417306","https://openalex.org/W2104836037","https://openalex.org/W2149989196","https://openalex.org/W7097936634","https://openalex.org/W3084918797","https://openalex.org/W1988767417"],"abstract_inverted_index":{"We":[0],"recently":[1],"reported":[2],"on":[3,115,287],"a":[4,36,264],"series":[5],"of":[6,61,144,171,187,203,223,229],"pyrrole":[7,90,110,117,130],"Mannich":[8],"bases":[9],"orally":[10],"active":[11,270],"in":[12,19,58,79,159,165,198],"inhibiting":[13],"the":[14,48,89,94,106,109,116,129,145,169,185,190,193,199],"conditioned":[15],"avoidance":[16],"response":[17],"(CAR)":[18],"rats.":[20],"These":[21],"compounds":[22,155],"exhibit":[23],"affinity":[24],"for":[25,50,71,123],"both":[26],"D2":[27,204,251],"and":[28,31,55,101,108,119,140,232,240,242,253,276,279,293],"5-HT1A":[29,211,255],"receptors,":[30],"some":[32],"are":[33,272],"noncataleptogenic.":[34],"Such":[35],"profile":[37],"suggests":[38],"that":[39,258,268],"they":[40,259],"may":[41,260],"be":[42,77,261],"potential":[43],"antipsychotic":[44,284],"agents":[45,285],"which":[46,161],"lack":[47],"propensity":[49],"causing":[51],"extrapyramidal":[52],"side":[53,172],"effects":[54],"tardive":[56],"dyskinesias":[57],"humans.":[59],"One":[60],"these":[62],"compounds,":[63],"1-[[1-methyl-5-[[4-[2-(1-methylethoxy)phenyl]-":[64],"1-piperazinyl]methyl]-1H-pyrrol-2-yl]methyl]-2-piperidinone":[65],"(RWJ":[66],"25730,":[67],"1),":[68],"was":[69,179,214],"chosen":[70],"further":[72],"development":[73],"but":[74],"found":[75],"to":[76,84,93,195],"unstable":[78],"dilute":[80,166],"acid.":[81,167],"In":[82,125,168],"order":[83],"improve":[85],"stability,":[86],"we":[87,127],"replaced":[88,128],"methylene":[91],"linkage":[92],"piperazine":[95],"ring":[96],"with":[97,132,148,157,184,217,246],"ethylene,":[98],"employed":[99],"ethylene":[100],"dicarbonyl":[102],"as":[103,283],"linkers":[104],"between":[105],"lactam":[107,175],"ring,":[111,118],"placed":[112],"electron-withdrawing":[113],"groups":[114],"substituted":[120],"acyclic":[121],"amide":[122],"lactam.":[124],"addition,":[126],"segment":[131,147],"other":[133],"heterocycles":[134],"including":[135],"thiophene,":[136,149],"furan,":[137,150],"isoxazole,":[138],"isoxazoline,":[139,151],"pyridine.":[141],"Generally,":[142],"replacement":[143],"N-methylpyrrole":[146],"or":[152,174,182,201,249,267],"pyridine":[153,243],"afforded":[154],"equipotent":[156],"1":[158,196],"CAR,":[160],"were":[162],"more":[163],"stable":[164],"case":[170],"chain":[173],"modifications,":[176],"CAR":[177,227,289],"activity":[178],"significantly":[180],"decreased":[181],"abolished,":[183],"exception":[186],"6.":[188],"For":[189],"most":[191],"part,":[192],"modifications":[194],"resulted":[197],"decrease":[200],"loss":[202],"receptor":[205,212],"binding.":[206],"However,":[207],"within":[208],"this":[209],"series,":[210],"binding":[213,252,256],"greatly":[215],"increased,":[216],"thiophene":[218,234],"40":[219],"exhibiting":[220],"an":[221],"IC50":[222],"0.07":[224],"nM.":[225],"The":[226],"activities":[228],"pyrroles":[230],"6":[231,275],"12,":[233],"40,":[235],"furans":[236,277],"44-47,":[237],"isoxazolines":[238],"49":[239],"50,":[241],"54":[244],"coupled":[245],"their":[247,288],"weak":[248],"nonexistent":[250],"strong":[254],"suggest":[257],"acting":[262],"via":[263],"nondopaminergic":[265],"mechanism":[266],"dopaminergic":[269],"metabolites":[271],"responsible.":[273],"Pyrrole":[274],"44":[278],"47":[280],"show":[281],"promise":[282],"based":[286],"activity,":[290],"receptor-binding":[291],"profile,":[292],"solution":[294],"stability.":[295]},"counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}